Resistance-associated mutations in the human immunodeficiency virus type 1 subtype c protease gene from treated and untreated patients in the United Kingdom

J Clin Microbiol. 2001 Jul;39(7):2652-4. doi: 10.1128/JCM.39.7.2652-2654.2001.

Abstract

This work reports the variability of human immunodeficiency virus type 1 (HIV-1) protease from treated and untreated patients infected with HIV-1 subtype C in the United Kingdom. The most common primary mutation observed in treated patients was L90M. D30N, M46I, V82A/F, and I84V were seen rarely. M36I and I93L mutations were observed in nearly all samples from both treated and untreated patients and so cannot be considered as resistance-associated mutations in this subtype.

MeSH terms

  • Diseases in Twins
  • Drug Resistance, Microbial / genetics
  • HIV Infections / drug therapy
  • HIV Infections / virology*
  • HIV Protease / genetics*
  • HIV Protease Inhibitors / pharmacology*
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1 / classification
  • HIV-1 / drug effects*
  • HIV-1 / enzymology
  • HIV-1 / genetics
  • Humans
  • Infant
  • Mutation*
  • Twins
  • United Kingdom

Substances

  • HIV Protease Inhibitors
  • HIV Protease